Imaging features of ß-catenin-activated hepatocellular adenoma with weak ß-catenin activation: A rare case report.
Acta Radiol Open
; 11(11): 20584601221142241, 2022 Nov.
Article
in En
| MEDLINE
| ID: mdl-36439281
We report valuable imaging findings in a case of ß-catenin-activated hepatocellular adenoma (ß-HCA) with weak ß-catenin activation. A 40 year-old female presented with a liver tumor in S8 that was incidentally detected on ultrasonography. The tumor showed marked enhancement and early venous drainage into the middle hepatic vein in the arterial phase of contrast-enhanced computed tomography (CT). The tumor revealed slight hypointensity in the hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging (EOB-MRI). Six months after detection, the tumor had increased in size and a biopsy indicated hepatocellular carcinoma. The tumor was resected and pathologically diagnosed as ß-HCA with weak ß-catenin activation such as exon 3 S45 mutation and exon 7/8 mutation. Marked enhancement in the arterial phase of CT and MRI is a characteristic finding of ß-HCA with weak ß-catenin activation. Furthermore, the degree of ß-catenin activation might determine the signal intensity of ß-HCA in the hepatobiliary phase of EOB-MRI.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Acta Radiol Open
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: